Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response

Overview of attention for article published in Cancer Discovery, February 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 2 news outlets
twitter: 119 X users

patent: 4 patents

Readers on

mendeley: 180 Mendeley

Summary News X Patents

So far, Altmetric has seen 3 news stories from 2 outlets.

Compass Therapeutics : Survey of CTX-009 Patient Selection Hypotheses Using Real World Biliary Tract Cancer Data

MarketScreener, 17 Apr 2024

Survey of CTX-009 Patient Selection Hypotheses Using Real World Biliary Tract Cancer Data Minori Rosales, Thomas Schuetz, Anna…

New methodology of TMB assessment from tissue and liquid biopsy in NSCLC

PLoS Medicine, 26 Sep 2022

by Ľudmila Křížová, Markéta Šafaříková, Marta Kalousová, Lucie Pfeiferová, Aleš Antonín Kuběna, Michal Vočka, Jan Ulrych, Věra…

PERSONALIS : Leveraging RNA Sequencing Data in Predicting Immunotherapy Response

MarketScreener, 29 Jun 2021

Leveraging RNA Sequencing Data in Predicting Immunotherapy Response Erin Newburn, MS, PhD Director, Field Application Scientist…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.